Part ofhealthcare →

HR10133FEDERALin_committee

U.S. House introduces Fair Prescription Pricing Act of 2026

Original title: Fair Prescription Pricing Act of 2026

August 20, 2026

healthcare prescription drugs federal legislation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Aug 20, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This bill initiates the legislative process for potential changes to prescription drug price regulation, which could impact costs for patients and insurance providers nationwide.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Prescription drug consumers

The bill's stated purpose regarding prescription pricing suggests potential future changes to consumer costs.

Pharmaceutical industry

Legislative changes to prescription pricing directly impact the operational and pricing models of pharmaceutical companies.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

The Fair Prescription Pricing Act of 2026 has been introduced in the U.S. House of Representatives to address prescription drug costs. The bill is currently undergoing initial review by the Committees on Energy and Commerce, Ways and Means, and Education and Workforce.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This bill initiates the legislative process for potential changes to prescription drug price regulation, which could impact costs for patients and insurance providers nationwide.

Frequently Asked Questions

What does the Fair Prescription Pricing Act of 2026 do?

The provided document does not contain the specific policy provisions or regulatory changes proposed by the bill.

What is the current status of this bill?

The bill was introduced on August 20, 2026, and has been referred to three House committees for consideration.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Connected Entities

organizationCommittee on Energy and Commerce“Committee assigned to review the bill.”Map →

organizationCommittee on Ways and Means“Committee assigned to review the bill.”Map →

organizationCommittee on Education and Workforce“Committee assigned to review the bill.”Map →

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools